Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief
Proceedings of the National Academy of Sciences · 30.05.2023 · 120 (22)
DOI: 10.1073/pnas.2220979120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 22.05.2023. Verfasst von Alan Hegron und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY 10010. Hauptthemen laut MEDLINE: Receptors, Neurokinin-1, Endosomes. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, NIDDK NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
The hypothesis that sustained G protein-coupled receptor (GPCR) signaling from endosomes mediates pain is based on studies with endocytosis inhibitors and lipid-conjugated or nanoparticle-encapsulated antagonists targeted to endosomes. GPCR antagonists that reverse sustained endosomal signaling and nociception are needed. However, the criteria for rational design of such compounds are ill-defined. Moreover, the role of natural GPCR variants, which exhibit aberrant signaling and endosomal trafficking, in maintaining pain is unknown. Herein, substance P (SP) was found to evoke clathrin-mediated assembly of endosomal signaling complexes comprising neurokinin 1 receptor (NK 1 R), Gα q/i , and βarrestin-2. Whereas the FDA-approved NK 1 R antagonist aprepitant induced a transient disruption of endosomal signals, analogs of netupitant designed to penetrate membranes and persist in acidic endosomes through altered lipophilicity and pKa caused sustained inhibition of endosomal signals. When injected intrathecally to target spinal NK 1 R+ve neurons in knockin mice expressing human NK 1 R, aprepitant transiently inhibited nociceptive responses to intraplantar injection of capsaicin. Conversely, netupitant analogs had more potent, efficacious, and sustained antinociceptive effects. Mice expressing C-terminally truncated human NK 1 R, corresponding to a natural variant with aberrant signaling and trafficking, displayed attenuated SP-evoked excitation of spinal neurons and blunted nociceptive responses to SP. Thus, sustained antagonism of the NK 1 R in endosomes correlates with long-lasting antinociception, and domains within the C-terminus of the NK 1 R are necessary for the full pronociceptive actions of SP. The results support the hypothesis that endosomal signaling of GPCRs mediates nociception and provides insight into strategies for antagonizing GPCRs in intracellular locations for the treatment of diverse diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY 10010.
- Department of Neuroscience and Physiology, Neuroscience Institute, New York University, New York, NY 10010.
- Pain Research Center, College of Dentistry, New York University, New York, NY 10010.
- Department of Chemistry and Pharmacy, Friedrich-Alexander Universität Erlangen-Nürnberg, 91058, Erlangen, Germany.
- Gene Modification Platform, Monash University, Clayton, VIC 3168, Australia.
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
ORCID-Profile: Chloe J Peach, Raquel Tonello, Philipp Seemann, Shavonne Teng, Rocco Latorre, Dorothee Weikert, Nicholas A Veldhuis, Daniel P Poole, Dane D Jensen, Wendy L Imlach, Peter Gmeiner, Nigel W Bunnett
Förderung
- NIDCR NIH HHS
- NIDDK NIH HHS
- NINDS NIH HHS
- HHS | National Institutes of Health
- U.S. Department of Defense
- DHAC | National Health and Medical Research Council
- Department of Education and Training | Australian Research Council
- Leon Levy Foundation
Zitieren
APA
Hegron, A., Peach, C. J., Tonello, R., Seemann, P., Teng, S., Latorre, R., Huebner, H., Weikert, D., Rientjes, J., Veldhuis, N. A., Poole, D. P., Jensen, D. D., Thomsen, A. R. B., Schmidt, B. L., Imlach, W. L., Gmeiner, P., & Bunnett, N. W. (2023). Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief. Proceedings of the National Academy of Sciences, 120(22). https://doi.org/10.1073/pnas.2220979120
Vancouver
Hegron A, Peach CJ, Tonello R, Seemann P, Teng S, Latorre R, et al. Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief. Proceedings of the National Academy of Sciences. 2023;120(22). doi:10.1073/pnas.2220979120
BibTeX
@article{Hegron2023,
author = {Hegron, Alan and Peach, Chloe J and Tonello, Raquel and Seemann, Philipp and Teng, Shavonne and Latorre, Rocco and Huebner, Harald and Weikert, Dorothee and Rientjes, Jeanette and Veldhuis, Nicholas A and Poole, Daniel P and Jensen, Dane D and Thomsen, Alex R B and Schmidt, Brian L and Imlach, Wendy L and Gmeiner, Peter and Bunnett, Nigel W},
title = {Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {22},
doi = {10.1073/pnas.2220979120}
}
EUVIMED